The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in sales , its intellectual property lapse created Pharma a deluge of knock-off medications, significantly eroding its position . While some businesses may attempt to capitalize on related treatments